CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma.

Increased CCL5 levels are markers of an unfavourable outcome in patients with melanoma, breast, cervical, prostate, gastric or pancreatic cancer. Here, we have assessed the role played by CCL5/CCR5 interactions in the development of colon cancer. To do so, we have examined a number of human colorect...

Full description

Bibliographic Details
Main Authors: Béatrice Cambien, Peggy Richard-Fiardo, Babou F Karimdjee, Violette Martini, Bernard Ferrua, Bruno Pitard, Heidy Schmid-Antomarchi, Annie Schmid-Alliana
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22205974/?tool=EBI